Avita Therapeutics, Inc.
Avita Therapeutics, Inc. (RCEL) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 94 transactions totaling $4.4M, demonstrating a bearish sentiment with -$3.6M in net insider flow. The most recent transaction on Aug 28, 2025 involved a purchase of 10,000 shares valued at $45.0K.
RCEL Insider Activity Summary
Who Is Buying RCEL Stock?
No significant insider buying has been recorded for RCEL in the recent period.
Who Is Selling RCEL Stock?
No significant insider selling has been recorded for RCEL in the recent period.
Is Avita Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for RCEL is bearish with an Insider Alignment Score of 9/100 and a net flow of -$3.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
RCEL Frequently Asked Questions
Understanding RCEL Insider Activity
Insider trading at Avita Therapeutics, Inc. (RCEL) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading RCEL stock, having executed 94 transactions in the past 90 days. The most active insider is Michael S. Perry (Executive), who has made 20 transactions totaling $4.7M.
Related Tools
Track Avita Therapeutics, Inc. Insider Activity
Get notified when executives and directors at RCEL file new Form 4 transactions